Company: SXTPW
Filing Date: 2025-07-16
Form Type: 424B4
Source: 0001213900-25-064472
Chunk: 70

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-16
Form: 424B4
Chunk 70
---
 not necessarily complete. If
a contract or document has been filed as an exhibit to the registration statement, please see the copy of the contract or document that
has been filed. Each statement in this prospectus relating to a contract or document filed as an exhibit is qualified in all respects
by the filed exhibit. The SEC maintains an Internet website that contains reports, proxy statements and other information about issuers,
like us, that file electronically with the SEC. The address of that website is www.sec.gov.

We are subject to the information and reporting
requirements of the Exchange Act and, in accordance with this law, are required to file periodic reports, proxy statements and other information
with the SEC. These periodic reports, proxy statements and other information are available for inspection and copying at the SEC’s
public reference facilities and the website of the SEC referred to above. We also maintain a website at https://60degreespharma.com/.
You may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished
to, the SEC. Information contained on our website is not a part of this prospectus and the inclusion of our website address in this prospectus
is an inactive textual reference only.

<div align='center'>38

1,753,314 Shares of Common Stock

Series A-1 Warrants to Purchase up to 1,753,314 Shares of Common Stock

Series A-2 Warrants to Purchase up to 1,753,314 Shares of Common Stock

878,264 Pre-Funded Warrants to Purchase up to 878,264 Shares of Common Stock
Series A-1 Warrants to Purchase up to 878,264 Shares of Common Stock

Series A-2 Warrants to Purchase up to 878,264 Shares of Common Stock

Up to 6,141,420 Shares of Common Stock Issuable Upon Exercise of the Series A-1 Warrants, Series A-2 Warrants and Pre-Funded Warrants

60 Degrees Pharmaceuticals, Inc.

PROSPECTUS

H.C. Wainwright & Co.

July 15, 2025</div>